We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$757M
AUM Growth
+$293M
Cap. Flow
+$210M
Cap. Flow %
27.7%
Top 10 Hldgs %
37.11%
Holding
384
New
211
Increased
9
Reduced
13
Closed
104

Top Buys

Rank Stock Value
1
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$19.6M
2
SPRU icon
Spruce Power Holding Corp
SPRU
+$16.2M
3
SHC icon
Sotera Health
SHC
+$10.7M
4
FHTX icon
Foghorn Therapeutics
FHTX
+$10.7M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$38.1M
2
CZR icon
Caesars Entertainment
CZR
+$18.8M
3
GDRX icon
GoodRx Holdings
GDRX
+$8.9M
4
SNOW icon
Snowflake
SNOW
+$6.28M
5
STEP icon
StepStone Group
STEP
+$5.99M

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Financials 10.57%
3 Consumer Discretionary 9%
4 Technology 5.91%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMAC
151
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$1.06M 0.14%
+99,999
New +$1.04M
DMRA
152
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$1.05M 0.14%
+3,367
New +$1.25M
PHICU
153
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$1.04M 0.14%
+100,000
New +$1.03M
BURU
154
DELISTED
NUBURU INC
BURU
$1.04M 0.14%
+501
New +$989K
MP.WS
155
DELISTED
MP Materials Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at
MP.WS
$1.02M 0.14%
+66,666
New +$690K
GAN
156
DELISTED
GAN Ltd
GAN
$1.01M 0.13%
+50,000
New +$838K
HLLY icon
157
Holley
HLLY
$382M
$1M 0.13%
+99,996
New +$992K
HOOK
158
DELISTED
HOOKIPA Pharma
HOOK
$998K 0.13%
+9,000
New +$972K
REPL icon
159
Replimune Group
REPL
$1.15B
$954K 0.13%
+25,000
New +$1.04M
HYFM icon
160
Hydrofarm Holdings
HYFM
$9.29M
$932K 0.12%
+1,772
New +$928K
OPT
161
DELISTED
Opthea Limited American Depositary Shares
OPT
$932K 0.12%
+83,100
New +$1.05M
SNDX icon
162
Syndax Pharmaceuticals
SNDX
$1.82B
$890K 0.12%
+40,000
New +$830K
LPRO
163
DELISTED
Open Lending Corp
LPRO
$874K 0.12%
+25,000
New +$727K
SPFR.U
164
DELISTED
JAWS Spitfire Acquisition Corp Units, each consisting of one Class A ordinary share, and one-fourth
SPFR.U
$829K 0.11%
+75,000
New +$811K
FREEW
165
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$804K 0.11%
582,406
– –
GFX.U
166
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$780K 0.1%
+75,000
New +$780K
KINZU
167
DELISTED
KINS Technology Group Inc. Unit
KINZU
$772K 0.1%
+75,000
New +$771K
CDTX
168
DELISTED
Cidara Therapeutics
CDTX
$738K 0.1%
18,455
– –
RAACU
169
DELISTED
Revolution Acceleration Acquisition Corp Unit
RAACU
$729K 0.1%
+70,000
New +$725K
SA
170
Seabridge Gold
SA
$3.36B
$716K 0.09%
+34,000
New +$658K
VIRX
171
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$693K 0.09%
+99,564
New +$520K
BCAB icon
172
BioAtla
BCAB
$5.76M
$680K 0.09%
+400
New +$669K
VINCW
173
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
$660K 0.09%
+200,000
New +$665K
PNT
174
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$658K 0.09%
47,271
– –
MRACU
175
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$650K 0.09%
+60,000
New +$641K
5 6
7
8 9

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Monashee Investment Management held 384 positions worth $757M, up 63% from $464M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management deployed $210M of net new capital in Q4 2020, opening 211 new positions and adding to 9 existing holdings. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $38.1M trimmed.

  • Monashee Investment Management's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.
  • Monashee Investment Management added most to Quanterix in Q4 2020, an estimated $8.95M increase.
  • Monashee Investment Management's biggest Q4 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $38.1M.
  • Monashee Investment Management fully exited Caesars Entertainment in Q4 2020, selling an estimated $18.8M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $757M portfolio in Q4 2020.
  • Monashee Investment Management opened 211 new positions and closed 104 in Q4 2020.
  • Monashee Investment Management's portfolio value rose 63% quarter-over-quarter to $757M.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.